candesartan has been researched along with Hydronephrosis in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Hydronephrosis: Abnormal enlargement or swelling of a KIDNEY due to dilation of the KIDNEY CALICES and the KIDNEY PELVIS. It is often associated with obstruction of the URETER or chronic kidney diseases that prevents normal drainage of urine into the URINARY BLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we examined the effects of the ANG II receptor type 1 (AT1R) blockade using candesartan on long-term renal molecular and functional changes in response to partial unilateral ureteral obstruction (PUUO)." | 7.74 | Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. ( Djurhuus, JC; Frøkiaer, J; Jørgensen, TM; Knepper, M; Nielsen, S; Nørregaard, R; Pedersen, M; Topcu, SO; Wang, G, 2007) |
| " Here, we examined the effects of the ANG II receptor type 1 (AT1R) blockade using candesartan on long-term renal molecular and functional changes in response to partial unilateral ureteral obstruction (PUUO)." | 3.74 | Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. ( Djurhuus, JC; Frøkiaer, J; Jørgensen, TM; Knepper, M; Nielsen, S; Nørregaard, R; Pedersen, M; Topcu, SO; Wang, G, 2007) |
| "Hydronephrosis was induced by ligation of the left ureter in 8-week-old stroke-prone spontaneously hypertensive rats." | 1.29 | Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles. ( Goto, A; Hayakawa, H; Hirata, Y; Kimura, K; Omata, M; Tojo, A, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topcu, SO | 1 |
| Pedersen, M | 1 |
| Nørregaard, R | 1 |
| Wang, G | 1 |
| Knepper, M | 1 |
| Djurhuus, JC | 1 |
| Nielsen, S | 1 |
| Jørgensen, TM | 1 |
| Frøkiaer, J | 1 |
| Kimura, K | 1 |
| Tojo, A | 1 |
| Hirata, Y | 1 |
| Hayakawa, H | 1 |
| Goto, A | 1 |
| Omata, M | 1 |
2 other studies available for candesartan and Hydronephrosis
| Article | Year |
|---|---|
Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Aquaporin 2; Benzim | 2007 |
Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arterioles; Benzimidazoles; Biph | 1994 |